Restricted accessLetterFirst published online April, 2022

Commentary on Aschmann et al: How do we incorporate harms in analyses of randomized trials?

Volume 19, Issue 2https://doi.org/10.1177/17407745211068547

Abstract

Get full access to this article

View all access options for this article.

References

1.

Aschmann

HE

McNeil

JJ

Puhan

MA

. Large scale prevention trials could provide stronger evidence for decision makers: opportunities to design and report with a focus on the benefit-harm balance. Clin Trials, IN PRESS.